Novus Diagnostics
PrivateLast Round
Series A
Oct 25, 2024
Est. Valuation
$20M
Total Funding Raised
$14M
Company Overview
Novus Diagnostics operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Series A round in October 2024.
Novus Diagnostics is a medical device company that develops rapid point-of-care diagnostic solutions for the detection and classification of infectious diseases, specifically sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novus Diagnostics Comparables
Compare Novus Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deepull | 87% | |
| Abionic SA | 86% | |
| Eroica Dx | 83% |
For institutional investors. Book with your work email.
Novus Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 25, 2024 | ||||
| VC Round | Nov 21, 2022 | ||||
| Grant | Jan 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novus Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Venture Partners | Series A |
| Irrus Investments | Series A |
| European Innovation Council Fund | VC Round, Grant |
| Enterprise Ireland | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2024
$5M round led by Business Venture Partners, Irrus Investments, and Trinity Biotech plc.
- Apr 9, 2024
Grew 23% QoQ, from 13 to 16 employees.
For institutional investors. Book with your work email.
Novus Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novus Diagnostics's valuation, stock price, and market status.
Is Novus Diagnostics a public or private company?
Novus Diagnostics is a private company.
What is the current stock price of Novus Diagnostics?
Novus Diagnostics is a private company, so its shares have no public market price. Caplight tracks Novus Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novus Diagnostics worth (valuation)?
Novus Diagnostics's valuation is estimated at $20.0M based on funding round data.
Can I buy Novus Diagnostics stock?
Novus Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novus Diagnostics's last funding round?
Novus Diagnostics's most recent funding round was Series A on October 25, 2024.
Who are the main investors in Novus Diagnostics?
Key investors in Novus Diagnostics include Business Venture Partners, Irrus Investments.
Will Novus Diagnostics IPO soon?
No public IPO plans have been announced for Novus Diagnostics.
How can I track Novus Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Novus Diagnostics's shares on secondary markets.